Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAUMADORNASE
NCT03368092Phase 3Recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Mar 2019
- Primary completion
- Sep 2027
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dornase alfa in acute respiratory distress syndrome (ARDS), sponsored by Strasbourg University Hospital. Started Mar 2019; status: recruiting.
02
Drugs
dornase alfa
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT03368092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03368092.